Getinge (OTCMKTS:GNGBY) Issues Quarterly Earnings Results

Getinge (OTCMKTS:GNGBY) posted its earnings results on Tuesday. The company reported $0.47 EPS for the quarter, Zacks reports. Getinge had a return on equity of 10.64% and a net margin of 5.77%.

Getinge Stock Performance

GNGBY stock opened at $23.62 on Tuesday. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.34 and a quick ratio of 0.80. The business’s 50-day moving average is $23.02 and its two-hundred day moving average is $22.23. Getinge has a fifty-two week low of $17.70 and a fifty-two week high of $24.67.

Analyst Ratings Changes

Separately, Nordea Equity Research raised Getinge from a “hold” rating to a “buy” rating in a research report on Wednesday, October 22nd. One investment analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy”.

Getinge Company Profile

Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company’s offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge’s solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.

The company’s product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.